Condition
Opioid Craving
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (2)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05511909Phase 2Recruiting
Evaluating Buspirone to Treat Opioid Withdrawal
NCT05109429Not ApplicableCompletedPrimary
Developing a Clinical Outcome Assessment for Opioid Craving
NCT07361731Not ApplicableCompleted
Evaluating the Feasibility, Acceptability, and Preliminary Outcomes of Heart Rate Variability Biofeedback for Individuals With Opioid Use Disorder.
NCT05027919Phase 2Recruiting
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
NCT04238754Phase 1Completed
Oral Cannabidiol for Opioid Withdrawal
Showing all 5 trials